Technology

Mounjaro leads South Africa’s $187 million weight-loss drug boom as Aspen prepares Ozempic rival

South Africa’s market for popular diabetes and weight-management medicines has grown to almost $187 million (R3 billion), with Mounjaro leading sales as Aspen Pharmacare prepares a generic alternative to medicines such as Ozempic. South Africa’s market for GLP-1 medicines is approaching $187 million (R3 billion).…

Business Insider AfricaBy Ayodeji Adegboyega3 September 2026 at 15:14 UTC · 1d ago

Mounjaro leads South Africa’s $187 million weight-loss drug boom as Aspen prepares Ozempic rival — Image via Business Insider Africa

Read the full story

Africa Business Review aggregates and summarises reporting from trusted publishers. The full article is published by Business Insider Africa.

Read at Business Insider Africa →

Original headline: “Mounjaro leads South Africa’s $187 million weight-loss drug boom as Aspen prepares Ozempic rival”

Local Markets